2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSeidu, S.
dc.contributor.authorCos, X.
dc.contributor.authorBrunton, S.
dc.contributor.authorHarris, S. B.
dc.contributor.authorJansson, S. P. O.
dc.contributor.authorMata\\-Cases, M.
dc.contributor.authorNeijens, A. M. J.
dc.contributor.authorTopsever, P.
dc.contributor.authorKhunti, K.
dc.date.accessioned2025-10-16T15:17:36Z
dc.date.issued2022
dc.identifier.doi10.1016/j.pcd.2022.02.002
dc.identifier.otherWOS:000813410400001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6969
dc.publisherELSEVIER SCI LTD
dc.sourcePRIMARY CARE DIABETES
dc.subjectType 2 diabetes
dc.subjectCardiovascular disease
dc.subjectCardiovascular risk factors
dc.subjectMultimorbidity
dc.subjectTherapeutic inertia
dc.subjectTherapeutic adherence
dc.subjectHeart failure
dc.subjectChronic kidney disease
dc.subjectElderly
dc.subjectPrimary care
dc.subjectPatient\\-centred care
dc.subjectShared decision making
dc.title2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS